Unicycive Therapeutics UNCY
NASDAQ UNCY
$3.89 -0.05 (-1.27%)
At close: Oct 23, 2026 · 4:00 PM EDT

Unicycive Therapeutics (UNCY) Price to Sales (2023)

Updated

Unicycive Therapeutics' Price to Sales came in at 31.56 for Q4 2023, down 28.7% from the prior quarter.

Analysis

Unicycive Therapeutics (UNCY) Price to Sales (2023) Analysis & Trends

  • Going back by year, Price to Sales was 8.65 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Unicycive Therapeutics 104.44 Mn -95.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 31.56
Sep 30, 2023 44.28
Jun 30, 2023 11.99
API Access

Unicycive Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=UNCY&period=max&api_key=YOUR_API_KEY